Current role of beta-adrenergic blockers in the management of chronic heart failure
- 1 May 2001
- journal article
- review article
- Published by Elsevier in The American Journal of Medicine
- Vol. 110 (7) , 81-94
- https://doi.org/10.1016/s0002-9343(01)00676-3
Abstract
No abstract availableKeywords
This publication has 70 references indexed in Scilit:
- Safety and efficacy of carvedilol in severe heart failureJournal of Cardiac Failure, 1997
- The Effect of Carvedilol on Morbidity and Mortality in Patients with Chronic Heart FailureNew England Journal of Medicine, 1996
- Carvedilol improves left ventricular function and symptoms in chronic heart failure: A double-blind randomized studyJournal of the American College of Cardiology, 1995
- Nebivolol Increases Survival in Cardiomyopathic Hamsters with Congestive Heart FailureJournal of Cardiovascular Pharmacology, 1991
- Epinephrine-induced hypokalemia: The role of beta adrenoceptorsThe American Journal of Cardiology, 1986
- Improvement in symptoms and exercise tolerance by metoprolol in patients with dilated cardiomyopathy: a double-blind, randomized, placebo-controlled trial.Circulation, 1985
- Coronary vasoconstriction and catecholamine cardiomyopathyAmerican Heart Journal, 1985
- Plasma Norepinephrine as a Guide to Prognosis in Patients with Chronic Congestive Heart FailureNew England Journal of Medicine, 1984
- Selectivity of the Intrinsic Sympathomimetic Activity of the β-Adrenergic Blocking Drug BucindololJournal of Cardiovascular Pharmacology, 1984
- Plasma norepinephrine in congestive heart failurePublished by Elsevier ,1978